Clinical severity and NT-proBNP levels were considerably higher in the Brouwers et al. and Müller-Tasch et al. studies than in ours, while previous studies showing significant associations included substantial percentages of patients with no manifest heart failure. This evidence concerns the gene NPPB and heart failure.